miR-223: a key regulator of pulmonary inflammation

Mingyu Shi; Qianying Lu; Yanmei Zhao; Ziling Ding; Sifan Yu; Junfeng Li; Mengjun Ji; Haojun Fan; Shike Hou

doi:10.3389/fmed.2023.1187557

miR-223: a key regulator of pulmonary inflammation

Front Med (Lausanne). 2023 Jul 3:10:1187557. doi: 10.3389/fmed.2023.1187557. eCollection 2023.

Authors

Mingyu Shi¹, Qianying Lu¹, Yanmei Zhao¹, Ziling Ding¹, Sifan Yu¹, Junfeng Li¹, Mengjun Ji¹, Haojun Fan^{1

2}, Shike Hou^{1

2}

Affiliations

¹ Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
² Wenzhou Safety (Emergency) Institute of Tianjin University, Wenzhou, China.

Abstract

Small noncoding RNAs, known as microRNAs (miRNAs), are vital for the regulation of diverse biological processes. miR-223, an evolutionarily conserved anti-inflammatory miRNA expressed in cells of the myeloid lineage, has been implicated in the regulation of monocyte-macrophage differentiation, proinflammatory responses, and the recruitment of neutrophils. The biological functions of this gene are regulated by its expression levels in cells or tissues. In this review, we first outline the regulatory role of miR-223 in granulocytes, macrophages, endothelial cells, epithelial cells and dendritic cells (DCs). Then, we summarize the possible role of miR-223 in chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), coronavirus disease 2019 (COVID-19) and other pulmonary inflammatory diseases to better understand the molecular regulatory networks in pulmonary inflammatory diseases.

Keywords: COVID-19; acute lung injury (ALI); asthma; chronic obstructive pulmonary disease (COPD); inflammatory disease; miR-223.

Publication types

Review